Basophil FcepsilonRI histamine release parallels expression of Src-homology 2-containing inositol phosphatases in chronic idiopathic urticaria.
about
EAACI taskforce position paper: evidence for autoimmune urticaria and proposal for defining diagnostic criteriaClinical efficacy of omalizumab in chronic spontaneous urticaria is associated with a reduction of FcεRI-positive cells in the skin.Effects of omalizumab on basophil and mast cell responses using an intranasal cat allergen challenge.Activated status of basophils in chronic urticaria leads to interleukin-3 hyper-responsiveness and enhancement of histamine release induced by anti-IgE stimulus.Suppression of basophil FcɛRI activation by serum from active chronic idiopathic/spontaneous urticaria (CIU/CSU) subjectsExpression profiling of human basophils: modulation by cytokines and secretagoguesDiagnosis and treatment of urticaria and angioedema: a worldwide perspective.New concepts in chronic urticaria.Cultured peripheral blood mast cells from chronic idiopathic urticaria patients spontaneously degranulate upon IgE sensitization: Relationship to expression of Syk and SHIP-2.Kinetics of mast cell, basophil, and oral food challenge responses in omalizumab-treated adults with peanut allergy.Basophils as critical orchestrators of Th2-type immune responses.Pathogenic intracellular and autoimmune mechanisms in urticaria and angioedema.Potential role of histamine releasing factor (HRF) as a therapeutic target for treating asthma and allergy.Pathogenesis of chronic urticaria: an overviewOmalizumab may not inhibit mast cell and basophil activation in vitro.Looking forward to new targeted treatments for chronic spontaneous urticaria.Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria.Cold urticaria: a 20-year follow-up study.Histamine Release from Mast Cells and Basophils.Treatment of chronic spontaneous urticaria.Development of a microarray-based method to detect exposure of human basophils to IL-3.Stability of Syk protein and mRNA in human peripheral blood basophils.Mediators of Inflammation and Angiogenesis in Chronic Spontaneous Urticaria: Are They Potential Biomarkers of the Disease?Chronic Spontaneous Urticaria: Pathogenesis and Treatment Considerations.Efficacy of leukotriene receptor antagonist with an anti-H1 receptor antagonist for treatment of chronic idiopathic urticaria.History of Histamine-Releasing Factor (HRF)/Translationally Controlled Tumor Protein (TCTP) Including a Potential Therapeutic Target in Asthma and Allergy.Interval shifts in basophil measures correlate with disease activity in chronic spontaneous urticaria.Functional and phenotypic analysis of basophils allows determining distinct subtypes in patients with chronic urticaria.Urticaria and Angioedema: an Update on Classification and Pathogenesis.SHIP negatively regulates type II immune responses in mast cells and macrophages.Statin effects on regulatory and proinflammatory factors in chronic idiopathic urticaria.
P2860
Q26828824-61B31932-1409-41EA-8E63-6E0EDCF196EEQ33588223-483A7C31-2FE0-4BBB-BE92-18D64B363113Q33774675-2107342F-978A-4BBF-BD7C-BC3490DE87A9Q34761812-575D1603-D835-46AA-A5D9-8F9F60E92DB7Q35478921-C1357A63-6C54-468D-86BA-09612CEC0CCAQ35626987-31DCA96A-7613-465D-B565-65A0834F2EDEQ36834774-E1D34726-2EC2-466B-8F26-D2579206FCAAQ37029360-394285AD-7231-4294-836D-B24E57D986E4Q37288124-0B142C9C-C4BD-49D4-92AF-16896A020B7BQ37604549-4686779D-8AC3-43B9-A1F9-179C5178BFDEQ37755330-E6EA2AE5-A686-48EF-87BA-AF1E74A694FFQ38016756-6B789C65-51CB-480F-9270-8F9D07DFBADBQ38051310-4EE040BE-96F4-41CB-81CB-D3ECAE79C313Q38239664-26C501E3-FFEA-4DF7-B0F7-58FDD5381AC6Q38254504-BD6CD51B-86E3-42A6-B55E-29D3F85CE7F4Q38771632-4AB7E100-696C-4D90-B16C-5DF2AFB57746Q39012896-6EE93D6D-D9C2-40D7-B8C6-B2A40974785AQ39596378-8725F312-71A6-48E4-BF77-DF97BD115516Q40282553-4E34D0F9-64F3-49B3-9C8A-185E898A9D80Q41786093-575C0B07-C13E-4ABB-B929-C120D2EC6255Q42350803-78187E26-B26A-4435-9248-B5EECEE009D2Q42360949-200C8A81-352B-4B02-9C00-FC6DF0F015C8Q42361136-91E9D498-1F6B-4F2E-931E-5ED74919D4D3Q42736757-ECD53CA4-7C1D-4ACA-B844-92F78A9E7260Q46196780-B16FDFE0-37C7-40D3-AD2B-1498AA069CBAQ47391528-2760A5AE-8ABD-4FE0-B606-0FC43EF5DBBCQ48051571-68536E7F-3892-4325-B8A9-B99F56650E14Q48323568-6AFE88A0-118A-4419-8AB5-4F361B0163E6Q48339085-30167E09-906A-410D-A3AF-26B6738B7A49Q49972870-66ACFE30-766F-47B6-AA41-C24876D76DD6Q53213843-79D08976-37C8-4595-A602-7F8DBFAC0B25
P2860
Basophil FcepsilonRI histamine release parallels expression of Src-homology 2-containing inositol phosphatases in chronic idiopathic urticaria.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Basophil FcepsilonRI histamine ...... chronic idiopathic urticaria.
@en
Basophil FcepsilonRI histamine ...... chronic idiopathic urticaria.
@nl
type
label
Basophil FcepsilonRI histamine ...... chronic idiopathic urticaria.
@en
Basophil FcepsilonRI histamine ...... chronic idiopathic urticaria.
@nl
prefLabel
Basophil FcepsilonRI histamine ...... chronic idiopathic urticaria.
@en
Basophil FcepsilonRI histamine ...... chronic idiopathic urticaria.
@nl
P2093
P1476
Basophil FcepsilonRI histamine ...... chronic idiopathic urticaria.
@en
P2093
Becky M Vonakis
Hyeyoun Chang
Kavitha Vasagar
Laura Gober
Patricia M Sterba
Sarbjit S Saini
Scott P Gibbons
P304
P356
10.1016/J.JACI.2006.09.035
P407
P577
2006-11-27T00:00:00Z